Industry News_Yinhe Biological Technology-Medical gel-Edible gum

Weihai Yinhe Biological Technology Co.,Ltd

Language

Our social account and

Video platform

Production, sales and research and development of pharmaceutical auxiliary materials

service provider

www.300.cn

News

Home page

Industry News

Company News

2017.02.18

Development Status and Existing Problems of Domestic Gelatin Industry

-China Economic Weekly 1. industry development status 1, the rapid development of the industry, the rapid expansion of market capacity China's gelatin industry is currently in a period of rapid development, the rapid expansion of market capacity, according to the statistics of China Gelatin Association, the market capacity of China's gelatin industry in the past decade has been growing at a compound annual growth rate of 2 digits.

read article

Development Status and Existing Problems of Domestic Gelatin Industry

2016.08.09

New Deal | CFDA to food additives "operation" 5 key points should pay special attention

On July 20, the official website of the State Food and Drug Administration issued the "Notice of the General Office of the General Administration on Further Strengthening the Supervision of the Production of Food Additives" (hereinafter referred to as the "Notice").

read article

New Deal | CFDA to food additives "operation" 5 key points should pay special attention

2015.04.17

The Long History of Chinese Medicinal Gelatin

Gelatin for medicinal use is a water-soluble high-molecular substance obtained by moderately hydrolyzing and thermally denaturing collagen present in the body of an animal. It is a protein with a relative molecular mass of 2X104~4.5X105. It is the most important protein component in animal skin, bone and tendon, such as collagen in the collagen fibers of the dermal connective tissue, accounting for about 98% of the dry matter of the dermis.

read article

The Long History of Chinese Medicinal Gelatin

2015.04.17

New Regulations on Supervision of Pharmaceutical Gelatin Excipients Highlight Five Measures

On August 2, the State Food and Drug Administration held a press conference to issue the relevant rules on strengthening the supervision and handling of pharmaceutical excipients. The Rules are clear and subject to classified supervision of pharmaceutical excipients; pharmaceutical preparation manufacturers must conduct quality audits of pharmaceutical excipients and establish supplier files. The rules will be implemented from February 1, 2013.

read article

New Regulations on Supervision of Pharmaceutical Gelatin Excipients Highlight Five Measures

2015.04.17

What are the differences between edible gelatin, medicinal gelatin and industrial gelatin?

The primary material is different. Edible gelatin and medicinal gelatin are made of animal skins and bones. There is a demand for the origin of animals. For example, animal materials from epidemic areas and epidemic diseases cannot be used. Industrial gelatin can be used for industrial purification of leather, epidemic areas, and epidemic materials. Therefore, the chromium content of edible gelatin and medicinal gelatin cooked by animal skin and bone is very low, while the chromium content of industrial gelatin is relatively high.

read article

What are the differences between edible gelatin, medicinal gelatin and industrial gelatin?

2015.04.17

The Core Technology of Pharmaceutical Gelatin Production

Because of the particularity of medicinal gelatin products, the raw materials cannot be the same as minerals or agricultural products. When the material comes out, there can be a variety of data mixed use, the uncertainty of the layout, to the material processing to bring a certain degree of difficulty. The early production of medicinal gelatin was small-scale, and the material was relatively single. It could be processed by pigskin of a slaughterhouse. Oxidase could be input according to the molecular layout of pigskin for hydrolysis and oxidation, and then extracted. And now the scale of medicinal gelatin production lead to a variety of raw materials, can be rich in pigskin, there are cowhide. Industrial medicinal gelatin also has substances such as bone, tendon and tendon. A single oxidase is not enough to differentiate various materials. The investment of various oxidases will not only form waste, but also cause mutual reactions to generate unknown products, making the production uncertain.

Weihai Yinhe Biotechnology Co., Ltd. (hereinafter referred to as Yinhe Biotechnology) has a total investment of 1.4 billion yuan, covers an area of 400 mu, and has a total construction area of 120000 square meters. The project is divided into three phases. The first phase of the project mainly produces pharmaceutical excipient gelatin and food additive gelatin.

Column Menu

Product Series